551 related articles for article (PubMed ID: 28460481)
21. NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways.
Meng F; Zhang S; Song R; Liu Y; Wang J; Liang Y; Wang J; Han J; Song X; Lu Z; Yang G; Pan S; Li X; Liu Y; Zhou F; Wang Y; Cui Y; Zhang B; Ma K; Zhang C; Sun Y; Xin M; Liu L
EBioMedicine; 2019 Jun; 44():237-249. PubMed ID: 31176678
[TBL] [Abstract][Full Text] [Related]
22. The hepatitis B virus X protein downregulates NF-κB signaling pathways through decreasing the Notch signaling pathway in HBx-transformed L02 cells.
Luo J; Zhou H; Wang F; Xia X; Sun Q; Wang R; Cheng B
Int J Oncol; 2013 May; 42(5):1636-43. PubMed ID: 23450368
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related hepatocellular carcinoma via ERK1/2 signaling.
Wang Y; Cai J; Zeng X; Chen Y; Yan W; Ouyang Y; Xiao D; Zeng Z; Huang L; Liu A
BMC Cancer; 2015 Oct; 15():821. PubMed ID: 26514586
[TBL] [Abstract][Full Text] [Related]
24. SUMOylated CPAP is required for IKK-mediated NF-κB activation and enhances HBx-induced NF-κB signaling in HCC.
Yang ST; Yen CJ; Lai CH; Lin YJ; Chang KC; Lee JC; Liu YW; Chang-Liao PY; Hsu LS; Chang WC; Hung WC; Tang TK; Liu YW; Hung LY
J Hepatol; 2013 Jun; 58(6):1157-64. PubMed ID: 23369793
[TBL] [Abstract][Full Text] [Related]
25. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation.
Mo SJ; Hou X; Hao XY; Cai JP; Liu X; Chen W; Chen D; Yin XY
Cancer Commun (Lond); 2018 Apr; 38(1):9. PubMed ID: 29764501
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.
Xie Q; Chen L; Shan X; Shan X; Tang J; Zhou F; Chen Q; Quan H; Nie D; Zhang W; Huang AL; Tang N
Int J Cancer; 2014 Aug; 135(3):635-46. PubMed ID: 24374650
[TBL] [Abstract][Full Text] [Related]
27. Short chain fatty acids delay the development of hepatocellular carcinoma in HBx transgenic mice.
McBrearty N; Arzumanyan A; Bichenkov E; Merali S; Merali C; Feitelson M
Neoplasia; 2021 May; 23(5):529-538. PubMed ID: 33945993
[TBL] [Abstract][Full Text] [Related]
28. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
[TBL] [Abstract][Full Text] [Related]
29. Activating mechanism of transcriptor NF-kappaB regulated by hepatitis B virus X protein in hepatocellular carcinoma.
Wang T; Wang Y; Wu MC; Guan XY; Yin ZF
World J Gastroenterol; 2004 Feb; 10(3):356-60. PubMed ID: 14760757
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.
Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y
Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183
[TBL] [Abstract][Full Text] [Related]
31. The X protein of hepatitis B virus inhibits apoptosis in hepatoma cells through enhancing the methionine adenosyltransferase 2A gene expression and reducing S-adenosylmethionine production.
Liu Q; Chen J; Liu L; Zhang J; Wang D; Ma L; He Y; Liu Y; Liu Z; Wu J
J Biol Chem; 2011 May; 286(19):17168-80. PubMed ID: 21247894
[TBL] [Abstract][Full Text] [Related]
32. 14-3-3ζ binds to hepatitis B virus protein X and maintains its protein stability in hepatocellular carcinoma cells.
Tang Y; Zhang Y; Wang C; Sun Z; Li L; Dong J; Zhou W
Cancer Med; 2018 Nov; 7(11):5543-5553. PubMed ID: 30358169
[TBL] [Abstract][Full Text] [Related]
33. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B X protein upregulates decoy receptor 3 expression via the PI3K/NF-κB pathway.
Liang DY; Sha S; Yi Q; Shi J; Chen Y; Hou Y; Chang Q
Cell Signal; 2019 Oct; 62():109346. PubMed ID: 31229617
[TBL] [Abstract][Full Text] [Related]
35. Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3.
Wang Y; Lu Y; Toh ST; Sung WK; Tan P; Chow P; Chung AY; Jooi LL; Lee CG
J Hepatol; 2010 Jul; 53(1):57-66. PubMed ID: 20447714
[TBL] [Abstract][Full Text] [Related]
36. α7nAChR-mediated recruitment of PP1γ promotes TRAF6/NF-κB cascade to facilitate the progression of Hepatocellular Carcinoma.
Wan C; Wu M; Zhang S; Chen Y; Lu C
Mol Carcinog; 2018 Nov; 57(11):1626-1639. PubMed ID: 30074282
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis B virus X protein stimulates IL-6 expression in hepatocytes via a MyD88-dependent pathway.
Xiang WQ; Feng WF; Ke W; Sun Z; Chen Z; Liu W
J Hepatol; 2011 Jan; 54(1):26-33. PubMed ID: 20937539
[TBL] [Abstract][Full Text] [Related]
38. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y
Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B virus X protein binding to hepsin promotes C3 production by inducing IL-6 secretion from hepatocytes.
Zhang M; Gu J; Zhang C
Oncotarget; 2016 Feb; 7(7):7780-800. PubMed ID: 26760961
[TBL] [Abstract][Full Text] [Related]
40. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
